[ Pobierz całość w formacie PDF ]
.9.Bennett, C.(2003) Responsibility to the public: Why communicating the facts isessential to the progress of stem cell research , Australasian Biotechnology13(3): 32 33.Bhardwaj, M.(2003) Global bioethics and international governance of biotech-nology , Asian Biotechnology and Development Review 6(1): 39 53.Bobin, F.(2003) Chine: Une puissance scientifique encore immature , LeMonde, 17 October, p.15.Bonte-Friedheim, R.and Ekdahl, K.(2004) World health.A flu threat harder tostop than SARS , International Herald Tribune, 12 April, p.8.Bowe, C.(2004) Cholesterol drug helps Pfizer sales soar to $12.5 bn , FinancialTimes (London), 21 April, p.15.Boyd, T.(2003) Novel seaweed compounds creating a Trans-Tasman link , Aus-tralasian Biotechnology 13(3): 39 42.Burton, J.(2004) Novartis decision boosts Singapore ambitions , FinancialTimes, 6 July, p.6.143 144 REFERENCESChoisy, M., Woelk, C.H., Guegan, J.F.and Robertson, D.(2004) Comparativestudy of adaptative molecular evolution in different human immunodeficiencyvirus groups and subtypes , Journal of Virology 78(4): 1962 1970.Clendennen, S.K., López-Gómez, R., Gómez-Lim, M., Arntzen, C.J.and May,G.D.(1998) The abundant 31-kilodalton banana pulp protein is homologousto class-III acidic chitinases , Phytochemistry 47: 613 619.Cookson, C.(2003) Genetics.DNA profiling: A double-edged sword of justice ,Financial Times, 19 December, p.9.Covello, P.(2003) Gene discovery and the supply of plant-derived drugs , PBIBulletin 1: 4 5.Dando, G.and Devine, P.(2003) Emerging companies and pre-seed invest-ment , Australasian Biotechnology 13(3): 24 26.Dyer, G.(2003a) EU approval process for drugs is a farce , Financial Times,28 October, p.17.Dyer, G.(2003b) Research boost for Viagra challenges , Financial Times, 17November, p.1.Dyer, G.(2003c) Aventis cancer drug has positive results , Financial Times, 6 7December, p.8.Dyer, G.(2004) UK loses sector leader.but Europe gains a major biotechnol-ogy player , Financial Times, 19 May, p.20.Elegant, S.(2004) Avian flu.Gauging the threat.Is a human pandemic next? ,Time, 9 February, pp.14 20.European Commission (2002) Wonders of life.Stories from life sciences research(from the Fourth and Fifth Framework Programmes).Luxembourg: Office ofOfficial Publications of the European Communities.Facchini, P.J.(2003) Prairie poppy fields: Why research on opium poppy is im-portant and relevant in Canada , PBI Bulletin 1: 6 8.Ferenczi, T.(2003) Le financement de la recherche sur les cellules souches em-bryonnaires divise les Européens , Le Monde, 24 September, p.7.Firn, D.(2003) European biotech s dogged fight to keep up , Financial Times,19 December, p.8.Firn, D.and Minder, R.(2004) UCB buys entry into biotech market.UCB likedthe data so much it bought the company , Financial Times, 19 May, pp.19 and20.Fogher, C., et al.(1999) Abstracts International Symposium on Plant Genetic En-gineering, Havana, Cuba, 6 10 December, p.224.Foster, L.(2004) Selling tight skin to the ageing masses , Financial Times, 21 22February, p.8.Francisco, A.de (2004) French bioindustry: Diverse and promising , EuropeanBiotechnology News 3(3): 38 41.Gabrielczyk, T.(2004) New spirit of entrepreneurship , European Biotechnol-ogy News 3(3): 3.Gorman, C.and Noble, K.(2004) Why some are getting diabetes , Time, 12January, pp.37 43.Graff, G.D.and Newcomb, J.(2003) Agricultural biotechnology at the crossroads.Part I.The changing structure of the industry.Cambridge, MA: BioEconomicResearch Associates (bio-eraTM). REFERENCES 145Greco, A.(2003) From bench to boardroom: Promoting Brazilian biotech ,Science 300: 1366 1367.Griffith, V.(2003a) Aventis and Genta add to biotech surge , Financial Times,11 September, p.19.Griffith, V.(2003b) Biogen Idec looks for critical mass in its pipeline , FinancialTimes, 19 December, p.22.Guterl, F.(2004) Clipping its wings.Scientists hope a new technique will helpthem develop a vaccine against the bird flu virus before it leaps to humans ,Newsweek, 9 February, pp.36 40.Hilgenfeld, R., et al.(2003) Coronavirus main proteinase (3CLpro) structure:Basis for design of anti-SARS drugs , Science, 13 June, pp.1763 1767.Japan Bioindustry Association (2003), JBA Letters 20(1).Kahn, A.(2002) La France veut mieux tirer parti du potentiel scientifique chi-nois , Le Monde, 13 November, p.III.Kahn, A.(2003a) La Chine se hisse au troisième rang mondial en recherche etdéveloppement , Le Monde, 4 November, p.V.Kahn, A.(2003b) Un plan sur cinq ans pour les biotechnologies , Le Monde,28 29 September, p.17.Kalb, C.(2004) The life in a cell , Newsweek, 28 June, pp.50 51.Khandelwal, A., et al.(1999) Abstracts International Symposium on Plant GeneticEngineering, Havana, Cuba, 6 10 December, p.223.Kolata, G.(2004) The ethics of testing drugs on patients who cannot affordthem , New York Times Le Monde, 21 22 March, p.7.Kourilsky, P.(2004) L éthique du Nord sacrifie les malades du Sud , Le Monde,8 9 February, pp.1 14.Langridge, W.H.R.(2000) Edible vaccines , Scientific American 283(3):48 53.Larrick, J.W., Yu, L., Chen, J., Jaiswal, S.and Wycoff, K.(2000) Production ofantibodies in transgenic plants , Biotecnología Aplicada 17(1): 45 46.Lean, G.(2004) GM rice to be grown for medicine , The Independent, 1 Febru-ary, p.2.Lemonick, M.D.(2003) Tomato vaccine , Time, 25 November.Lemonick, M.D.(2004) Cloning gets closer.A Korean team clones human cellsto fight disease kindling fears someone will go too far , Time, 23 February,pp.46 48.Leroy, Eric M., et al.(2004) Multiple Ebola virus transmission events and rapiddecline of Central African wildlife , Science 303(5655).Lorelle, V.(1999a) Les start-up de biotechnologies seront les groupes pharma-ceutiques de demain.Des molécules qui piègent la cocaïne dans le sang , LeMonde, 10 November, p.20.Lorelle, V
[ Pobierz całość w formacie PDF ]
